Image

Assessing Speech Perception and Amplification Benefit During Infancy

Recruiting
6 - 36 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this project is to compare aided and unaided speech discrimination among infants with hearing loss and a cohort of infants with typical hearing.

Working Hypothesis: Among this group of infants with hearing loss, performance will be significantly better when infants are tested while using amplification (i.e., aided condition) compared to when tested without amplification (i.e., unaided condition). Infants fit with optimally programmed amplification will perform similarly to the infants with typical hearing on speech discrimination tasks.

Eligibility

Inclusion Criteria:

  • Children between the ages of 6 months and 36 months (inclusive) at the time of enrollment.
  • English is the primary spoken language in the home
  • Demonstrated ability to complete a conditioned head turn via visual reinforcement audiometry (VRA)
  • If normal hearing

    -Normal hearing sensitivity bilaterally

  • If Hearing Loss
    • Children with diagnosis of bilateral sensorineural hearing ranging from mild to severe
    • Children currently using hearing aids
    • Children currently enrolled in intervention

Exclusion Criteria:

  • Children born earlier than 35 weeks gestation
  • Children with abnormal tympanometry on the day of testing
  • Children with concerns of secondary disabilities
  • Children with Auditory Neuropathy
  • Concerns of hearing loss in normal hearing children

Study details

Hearing Loss, Children With Hearing Differences, Amplification, Speech Perception

NCT05653999

University of Colorado, Denver

29 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.